Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation
Xian Sun, Yi‐Ting Huang, Sha Zhu, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 769-787
Open Access | Times Cited: 11

Showing 11 citing articles:

Bibliometric analysis of literature on natural medicines against chronic kidney disease from 2001 to 2024
Xiaoqing Shi, Hongmei Yin, Xiaodan Shi
Phytomedicine (2025), pp. 156410-156410
Closed Access
Therapeutic Effects of Quercetin on Renal Fibrosis and Injury
Wenbiao Wang, Wenjing Wu
Integrative Medicine in Nephrology and Andrology (2025) Vol. 12, Iss. 1
Closed Access
Integrated network pharmacology and metabolomics analysis to reveal the potential mechanism of Ershen Wan in ameliorating ulcerative colitis
Mingyang Wang, Meiyu Wan, Meijuan Liu, et al.
Journal of Ethnopharmacology (2025), pp. 119690-119690
Closed Access
Network pharmacology-based identification of key pharmacological pathways of epimedium acting on hepatocellular carcinoma
Yan Mei, G. Lai, R. Xiao
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100532-100532
Open Access
Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis
MinChao Feng, Luo Fang, Huimin Wu, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 3169-3192
Open Access | Times Cited: 7
Association between consumption of flavonol and its subclasses and chronic kidney disease in US adults: an analysis based on National Health and Nutrition Examination Survey data from 2007–2008, 2009–2010, and 2017–2018
Peijia Liu, Leile Tang, Guixia Li, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
An integrated study of Shenling Baizhu San against hyperuricemia: Efficacy evaluation, core target identification and active component discovery
Yu Wang, Zhijian Lin, Jing Huang, et al.
Journal of Ethnopharmacology (2022) Vol. 295, pp. 115450-115450
Closed Access | Times Cited: 10
Traditional Chinese Medicine: An Exogenous Regulator of Crosstalk between the Gut Microbial Ecosystem and CKD
Xian Sun, Wei Sun, Yi‐Ting Huang, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 3
Qigui-Yishen decoction delays renal fibrosis in mice with chronic kidney disease by regulating TM and PAI-1
Xun Lu, Xiao-Wen Wan
American Journal of Translational Research (2024) Vol. 16, Iss. 6, pp. 2358-2368
Open Access
Molecular characterization of PANoptosis-related genes in chronic kidney disease
Wentao Zhang, Hongwei Ge, Yuan Wei, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312696-e0312696
Open Access
A therapeutic approach to identify leading molecules from natural products and therapeutic targets in CKD by network pharmacology
Yugant Krishnakumar Talati, Anil Bhanudas Gaikwad
PharmaNutrition (2024), pp. 100421-100421
Closed Access
Page 1

Scroll to top